Process for making a metabotropic glutamate receptor positive allosteric modulator - 874

Details for Australian Patent Application No. 2011203993 (hide)

Owner AstraZeneca AB

Inventors Boyd, Alistair; Fielding, Mark Richard; Ford, James Gair; Frodsham, Lianne; Golden, Michael D; Leslie, Kevin William; McKeever-Abbas, Ben; Tomlin, Paula

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011203993

PCT Pub. Number WO2011/084098

Priority 61/293,012 07.01.10 US

Filing date 4 January 2011

Wipo publication date 14 July 2011

International Classifications

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07C 235/42 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 209/46 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/88 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/084098 Priority application(s): WO2011/084098

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204012-Carrier aggregation in wireless communication system

2011203989-System for modifying eye tissue and intraocular lenses